Ligand Pharmaceuticals Q2 2025 Earnings Preview

17 hours ago 1
  • Ligand Pharmaceuticals (NASDAQ:LGND) is scheduled to announce Q2 earnings results on Thursday, August 7th, before market open.
  • The consensus EPS Estimate is $1.42 (+115.2% Y/Y) and the consensus Revenue Estimate is $43.87M (+5.7% Y/Y).
  • Over the last 2 years, LGND

Recommended For You

More Trending News

Read Entire Article